Categories: Infectious disease, Oncology

Based in San Diego, California, Epitope Diagnostics Inc was established in 2003. The company has developed many innovative ELISA and rapid tests to meet the needs of health communities worldwide. They developed the first Fetuin A ELISA kit for the determination of alpha-1-HS-glycoprotein, and in 2004 developed the innovative, odourless and self-contained rapid test system for stool samples that was the basis for their range of EpiTuub products.

The fully automated Epitope ECL100 CLIA analyser has now been launched with an extensive panel of routine and niche chemiluminescence immunoassays covering a variety of clinical areas.